The store will not work correctly when cookies are disabled.
Sodium salt (5R,6R)-3-tert-butyl-6-hydroxymethyl-7-oxo-4-oxa-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
ID: ALA71312
PubChem CID: 44310260
Max Phase: Preclinical
Molecular Formula: C11H14NNaO5
Molecular Weight: 241.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)C1=C(C(=O)[O-])N2C(=O)[C@H](CO)[C@H]2O1.[Na+]
Standard InChI: InChI=1S/C11H15NO5.Na/c1-11(2,3)7-6(10(15)16)12-8(14)5(4-13)9(12)17-7;/h5,9,13H,4H2,1-3H3,(H,15,16);/q;+1/p-1/t5-,9+;/m0./s1
Standard InChI Key: SMXZLUQMLSNJAH-XEDRIYAZSA-M
Molfile:
RDKit 2D
19 19 0 0 0 0 0 0 0 0999 V2000
5.1250 -5.6000 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
5.6500 -3.0417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4375 -3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6500 -2.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8250 -3.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9125 -2.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8250 -2.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4250 -1.9625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6875 -4.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7375 -2.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2375 -3.6292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9792 -4.6417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5000 -4.2500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2375 -1.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4500 -0.8417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1125 -3.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8125 -1.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5125 -2.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4874 -1.2383 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 2 1 0
5 2 1 0
6 3 2 0
7 5 1 0
4 8 1 0
9 3 1 0
10 6 1 0
11 5 2 0
12 9 1 0
13 9 2 0
7 14 1 6
14 15 1 0
16 10 1 0
17 10 1 0
18 10 1 0
4 7 1 0
6 8 1 0
4 19 1 6
M CHG 2 1 1 12 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 241.24 | Molecular Weight (Monoisotopic): 241.0950 | AlogP: 0.14 | #Rotatable Bonds: 2 |
Polar Surface Area: 87.07 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.05 | CX Basic pKa: ┄ | CX LogP: -0.37 | CX LogD: -3.50 |
Aromatic Rings: ┄ | Heavy Atoms: 17 | QED Weighted: 0.67 | Np Likeness Score: 0.90 |
References
1. Wild H, Metzger K. (1993) Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization, 3 (11): [10.1016/S0960-894X(01)80926-4] |